↓ Skip to main content

Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia

Overview of attention for article published in Arthritis Research & Therapy, November 2013
Altmetric Badge

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
158 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia
Published in
Arthritis Research & Therapy, November 2013
DOI 10.1186/ar4375
Pubmed ID
Authors

Michael Spaeth, Cayetano Alegre, Serge Perrot, Youyu Grace Wang, Diane R Guinta, Sarah Alvarez-Horine, Irwin Jon Russell, the Sodium Oxybate Fibromyalgia Study Group

Abstract

The long-term safety and therapeutic response of sodium oxybate (SXB) in fibromyalgia syndrome (FM) patients were assessed for a combined period of up to 1 year in a prospective, multicenter, open-label, extension study in patients completing 1 of 2 phase 3 randomized, double-blind, controlled, 14-week trials that examined the efficacy and safety of SXB 4.5 g, SXB 6 g, and placebo for treatment of FM.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 158 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Australia 1 <1%
Unknown 156 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 19 12%
Researcher 18 11%
Student > Master 17 11%
Student > Bachelor 16 10%
Student > Postgraduate 12 8%
Other 30 19%
Unknown 46 29%
Readers by discipline Count As %
Medicine and Dentistry 53 34%
Nursing and Health Professions 14 9%
Psychology 11 7%
Neuroscience 5 3%
Biochemistry, Genetics and Molecular Biology 4 3%
Other 14 9%
Unknown 57 36%